A carregar...
Current Treatments for Surgically Resectable, Limited‐Stage, and Extensive‐Stage Small Cell Lung Cancer
The prevalence of small cell lung cancer (SCLC) has declined in the U.S. as the prevalence of tobacco use has declined. However, a significant number of people in the U.S. are current or former smokers and are at risk of developing SCLC. Routine histological or cytological evaluation can reliably ma...
Na minha lista:
Publicado no: | Oncologist |
---|---|
Autor principal: | Stinchcombe, Thomas E. |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
AlphaMed Press
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728020/ https://ncbi.nlm.nih.gov/pubmed/28778960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0204 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
-
Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms
Por: Stinchcombe, Thomas E., et al.
Publicado em: (2010) -
Novel Approaches of Chemoradiotherapy in Unresectable Stage IIIA and Stage IIIB Non-Small Cell Lung Cancer
Por: Stinchcombe, Thomas E., et al.
Publicado em: (2012) -
Immunotherapy for extensive stage small cell lung cancer
Por: Pacheco, Jose M.
Publicado em: (2020) -
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer
Por: Melosky, Barbara, et al.
Publicado em: (2020) -
SURGICAL TREATMENT OF PATIENTS WITH RESECTABLE NON SMALL CELL LUNG CANCER
Por: K. I. Kolbanov, et al.
Publicado em: (2015-01-01)